Section Arrow
Quote
INBX.NASDAQ
- Inhibrx Biosciences Inc.
Quotes are at least 15-min delayed:2026/04/16 13:18 EDT
Regular Hours
Last
 82.34
-1.255 (-1.50%)
Day High 
83.649 
Prev. Close
83.595 
1-M High
85.94 
Volume 
49.87K 
Bid
81.86
Ask
82.34
Day Low
80.81 
Open
83.47 
1-M Low
57.3 
Market Cap 
1.22B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 71.9 
20-SMA 67.95 
50-SMA 73.4 
52-W High 94.565 
52-W Low 10.84 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-9.04/-2.14
Enterprise Value
1.33B
Balance Sheet
Book Value Per Share
0.55
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.30M
Operating Revenue Per Share
0.04
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.5833+0.0393+7.22%-- 
PBMPsyence Biomedical Ltd.6.66+3.78+131.25%-- 
ALLOAllogene Therapeutics2.325+0.155+7.14%-- 
ATAIAtaiBeckley Inc4.035+0.035+0.88%-- 
ACHVAchieve Life Sciences4.7811+1.2311+34.68%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.